Literature DB >> 33063190

Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same.

Stanislav Sitkin1,2,3, Juris Pokrotnieks4,5.   

Abstract

The effects of deoxycholic acid (DCA) on the intestinal microbiota, bile acid (BA) metabolism, and intestinal epithelium can be influenced by various factors. Depending on the specific conditions, DCA can be "bad" (proinflammatory) or "good" (anti-inflammatory). Mouse models of colitis show an increase in conjugated BAs and gut dysbiosis, including DCA-related dysbiosis, with a significant decrease in bile salt hydrolase (bsh) gene-containing taxa. Human patients with inflammatory bowel disease demonstrate, primarily, a decrease in bile acid-inducible (bai) gene-containing taxa and a deficiency in secondary BAs, suggesting their anti-inflammatory role.

Entities:  

Keywords:  Bile acids; Deoxycholic acid; Gut dysbiosis; Inflammatory bowel disease; Intestinal inflammation; Intestinal microbiome; Ulcerative colitis

Year:  2020        PMID: 33063190     DOI: 10.1007/s10620-020-06650-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

1.  Unique dietary-related mouse model of colitis.

Authors:  Harris Bernstein; Hana Holubec; Carol Bernstein; Natalia Ignatenko; Eugene Gerner; Katerina Dvorak; David Besselsen; Lois Ramsey; Monique Dall'Agnol; Karen Ann Blohm-Mangone; Jose Padilla-Torres; Haiyan Cui; Harinder Garewal; Claire Margaret Payne
Journal:  Inflamm Bowel Dis       Date:  2006-04       Impact factor: 5.325

2.  Fucose Ameliorate Intestinal Inflammation Through Modulating the Crosstalk Between Bile Acids and Gut Microbiota in a Chronic Colitis Murine Model.

Authors:  Jun Ke; Ying Li; Chaoqun Han; Ruohang He; Rong Lin; Wei Qian; Xiaohua Hou
Journal:  Inflamm Bowel Dis       Date:  2020-05-12       Impact factor: 5.325

3.  Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon.

Authors:  Joseph B J Ward; Natalia K Lajczak; Orlaith B Kelly; Aoife M O'Dwyer; Ashwini K Giddam; Joan Ní Gabhann; Placido Franco; Murtaza M Tambuwala; Caroline A Jefferies; Simon Keely; Aldo Roda; Stephen J Keely
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-03-30       Impact factor: 4.052

4.  Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.

Authors:  Henri Duboc; Sylvie Rajca; Dominique Rainteau; David Benarous; Marie-Anne Maubert; Elodie Quervain; Ginette Thomas; Véronique Barbu; Lydie Humbert; Guillaume Despras; Chantal Bridonneau; Fabien Dumetz; Jean-Pierre Grill; Joëlle Masliah; Laurent Beaugerie; Jacques Cosnes; Olivier Chazouillères; Raoul Poupon; Claude Wolf; Jean-Maurice Mallet; Philippe Langella; Germain Trugnan; Harry Sokol; Philippe Seksik
Journal:  Gut       Date:  2012-09-19       Impact factor: 23.059

5.  Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome.

Authors:  Chuansheng Guo; Shujun Xie; Zhexu Chi; Jinhua Zhang; Yangyang Liu; Li Zhang; Mingzhu Zheng; Xue Zhang; Dajing Xia; Yuehai Ke; Linrong Lu; Di Wang
Journal:  Immunity       Date:  2016-09-28       Impact factor: 31.745

6.  Muramyl dipeptides: prospect for cancer treatments and immunostimulation.

Authors:  S Kotani; I Azuma; H Takada; M Tsujimoto; Y Yamamura
Journal:  Adv Exp Med Biol       Date:  1983       Impact factor: 2.622

7.  Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis.

Authors:  Xinyang Song; Ximei Sun; Sungwhan F Oh; Meng Wu; Yanbo Zhang; Wen Zheng; Naama Geva-Zatorsky; Ray Jupp; Diane Mathis; Christophe Benoist; Dennis L Kasper
Journal:  Nature       Date:  2019-12-25       Impact factor: 49.962

8.  Global chemical effects of the microbiome include new bile-acid conjugations.

Authors:  Robert A Quinn; Alexey V Melnik; Alison Vrbanac; Ting Fu; Kathryn A Patras; Mitchell P Christy; Zsolt Bodai; Pedro Belda-Ferre; Anupriya Tripathi; Lawton K Chung; Michael Downes; Ryan D Welch; Melissa Quinn; Greg Humphrey; Morgan Panitchpakdi; Kelly C Weldon; Alexander Aksenov; Ricardo da Silva; Julian Avila-Pacheco; Clary Clish; Sena Bae; Himel Mallick; Eric A Franzosa; Jason Lloyd-Price; Robert Bussell; Taren Thron; Andrew T Nelson; Mingxun Wang; Eric Leszczynski; Fernando Vargas; Julia M Gauglitz; Michael J Meehan; Emily Gentry; Timothy D Arthur; Alexis C Komor; Orit Poulsen; Brigid S Boland; John T Chang; William J Sandborn; Meerana Lim; Neha Garg; Julie C Lumeng; Ramnik J Xavier; Barbara I Kazmierczak; Ruchi Jain; Marie Egan; Kyung E Rhee; David Ferguson; Manuela Raffatellu; Hera Vlamakis; Gabriel G Haddad; Dionicio Siegel; Curtis Huttenhower; Sarkis K Mazmanian; Ronald M Evans; Victor Nizet; Rob Knight; Pieter C Dorrestein
Journal:  Nature       Date:  2020-02-26       Impact factor: 49.962

9.  Absence of Toxemia in Clostridioides difficile Infection: Results from Ultrasensitive Toxin Assay of Serum.

Authors:  Rebecca Sprague; Karolyne Warny; Nira Pollock; Kaitlyn Daugherty; Qianyun Lin; Hua Xu; Christine Cuddemi; Caitlin Barrett; Xinhua Chen; Alice Banz; Aude Lantz; Kevin W Garey; Anne J Gonzales-Luna; Carolyn D Alonso; Javier A Villafuerte Galvez; Ciarán P Kelly
Journal:  Dig Dis Sci       Date:  2020-11-08       Impact factor: 3.487

10.  Deoxycholic Acid-Mediated Sphingosine-1-Phosphate Receptor 2 Signaling Exacerbates DSS-Induced Colitis through Promoting Cathepsin B Release.

Authors:  Shengnan Zhao; Zizhen Gong; Xixi Du; Chunyan Tian; Lingyu Wang; Jiefei Zhou; Congfeng Xu; Yingwei Chen; Wei Cai; Jin Wu
Journal:  J Immunol Res       Date:  2018-05-09       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.